SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Telik, Inc. Announces the Publication of Two Reports in the Journal of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Telintra in Patients With Myelodysplastic Syndrome